Min‐Xu Zou
- Pharmacology top 0.2%
- Surgery top 2%
- Cellular and Molecular Neuroscience top 2%
- Cardiology and Cardiovascular Medicine top 5%
- Endocrinology, Diabetes and Metabolism top 5%
- Co-authors
- Kazuhiko TatemotoMasahiko FujinoYuji KawamataMasaki HosoyaChieko KitadaYugo HabataShoji FukusumiHaruo Onda
- Topics
- Apelin-related biomedical research (4 papers)Protein Kinase Regulation and GTPase Signaling (3 papers)Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers)
- Partner nations
- CanadaJapanUnited States
In The Last Decade
Min‐Xu Zou
11 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 78
- Pharmacology 1.8k
- Surgery 1.4k
- Cellular and Molecular Neuroscience 917
- Cardiology and Cardiovascular Medicine 503
- Endocrinology, Diabetes and Metabolism 405
Countries citing papers authored by Min‐Xu Zou
This map shows the geographic impact of Min‐Xu Zou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min‐Xu Zou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min‐Xu Zou more than expected).
Fields of papers citing papers by Min‐Xu Zou
This network shows the impact of papers produced by Min‐Xu Zou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min‐Xu Zou. The network helps show where Min‐Xu Zou may publish in the future.
Co-authorship network of co-authors of Min‐Xu Zou
This figure shows the co-authorship network connecting the top 25 collaborators of Min‐Xu Zou. A scholar is included among the top collaborators of Min‐Xu Zou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min‐Xu Zou. Min‐Xu Zou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 6 | |
| 2 | 63 | |
| 3 | 52 | |
| 4 | 55 | |
| 5 | 47 | |
| 6 | 133 | |
| 7 | 16 | |
| 8 | The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanismbreakdown → | 545 |
| 9 | 5 | |
| 10 | 83 | |
| 11 | Isolation and Characterization of a Novel Endogenous Peptide Ligand for the Human APJ Receptorbreakdown → | 1405 |
About Min‐Xu Zou
Min‐Xu Zou is a scholar working on Pharmacology, Endocrine and Autonomic Systems and Cell Biology, having authored 11 papers that have together received 2.4k indexed citations. Recurring topics across this work include Apelin-related biomedical research (4 papers), Protein Kinase Regulation and GTPase Signaling (3 papers) and Cardiovascular, Neuropeptides, and Oxidative Stress Research (3 papers). The work is most often cited by research in Pharmacology (1.8k citations), Cellular and Molecular Neuroscience (917 citations) and Surgery (1.4k citations). Min‐Xu Zou has collaborated with scholars based in Canada, Japan and United States. Frequent co-authors include Kazuhiko Tatemoto, Masahiko Fujino, Yuji Kawamata, Masaki Hosoya, Chieko Kitada, Yugo Habata, Shoji Fukusumi, Haruo Onda, Ryo Fujii and Shuji Hinuma. Their work appears in journals such as Journal of Biological Chemistry, Gastroenterology and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.